Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
04/28/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/10/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/10/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/11/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/10/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
01/24/2022 4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on NATURES SUNSHINE PRODUCTS INC
Txns: Acquired 711 shares @ $0
Acquired 9,558 shares @ $0
Acquired 25,000 shares @ $8.72, valued at $218k
11/12/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/12/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/11/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/05/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/12/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/12/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/11/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2020 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
12/13/2019 4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on NATURES SUNSHINE PRODUCTS INC
Txns: Acquired 14,125 shares @ $0
Acquired 25,000 shares @ $7.8, valued at $195k
11/12/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/12/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/10/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
01/31/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
12/06/2018 4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 4 on CONTRAFECT Corp
Txns: Sold 600,000 shares @ $2.04, valued at $1.2M
12/06/2018 3/A Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (10% Owner) has filed a Form 3/A on CONTRAFECT Corp
11/09/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/13/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/08/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/09/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/07/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/31/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/18/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
01/20/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy